… We systematically reviewed and meta-analysed clinical outcomes with direct oral anticoagulants
(DOAC: dabigatran, rivaroxaban, apixaban or edoxaban) for treatment of acute VTE. …

… oral anticoagulants (NOACs) such as rivaroxaban, dabigatran, and apixaban have been
developed as an alternative to conventional anticoagulants… of the present meta-analysis were to …

BACKGROUND & AIMS: A new generation of oral anticoagulants (nOAC), which includes
thrombin and factor Xa inhibitors, has been shown to be effective, but little is known about …

… Excluding these patients from the analysis did not alter our results. The only study that
randomized patients to receive aspirin or low-intensity oral anticoagulant with aspirin found no …

… Similarly, repeating our analyses with Comprehensive Meta Analysis software including
trials with extremely low or zero event rates did not change the results of the primary analyses (…

… analysis may be unable to provide the precise estimates of bleeding risk and consequences
of oral anticoagulant … Therefore, we conducted a meta‐analysis that aimed to assess the …

… Our findings offer clinicians a more comprehensive picture of the new oral anticoagulants as
… meta-analysis support the premise that compared with warfarin, the new oral anticoagulants…

… As far as we know, this study is the first overall analysis of the novel oral anticoagulants for
… By pooling results in this meta-analysis, the upper confidence limit of the relative risk for …

… To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world …
pair-wise meta-analyses using a random effect model and a random effect network meta-analysis …

… , that evaluated the use of a direct acting oral anticoagulant (DOAC), vitamin K antagonist,
or … for oral anticoagulation. Trials in participants only eligible for parenteral anticoagulation …